✦ LIBER ✦

Hydronephrosis in advanced ovarian carcinoma

✍ Scribed by B. Lund; H.H. Hansen

Book ID: 119053036
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 401 KB
Volume: 35
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(89)90005-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemohormonal therapy in advanced ovaria

Chemohormonal therapy in advanced ovarian carcinoma

✍ S. Jeppson; A. Kauppila; S. Kullander; A. Skryten 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Intestinal obstruction in advanced ovari

Intestinal obstruction in advanced ovarian carcinoma

✍ Clarence J. Schein; Joseph S. Krakauer 📂 Article 📅 1953 🏛 Elsevier Science 🌐 English ⚖ 678 KB

Primary debulking surgery in advanced ov

Primary debulking surgery in advanced ovarian carcinoma

✍ Sean Kehoe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB

Chemotherapy for advanced epithelial ova

Chemotherapy for advanced epithelial ovarian carcinoma

✍ Nelson Gustavo Neder Kalil; William Patrick McGuire III 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Advanced epithelial ovarian carcinoma du

Advanced epithelial ovarian carcinoma during pregnancy

✍ Shin-ichi Ishioka; Takuhiro Hayashi; Toshiaki Endo; Tsuyoshi Baba; Hiroyuki Honm 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 280 KB

Advanced ovarian carcinoma. Factors infl

Advanced ovarian carcinoma. Factors influencing survival

✍ Baruch Klein; Geoffrey Falkson; C. F. Smit 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

One hundred ten patients with advanced ovarian carcinoma (Stages IIIA, IIIB, and 1V) were evaluated for survival. They received as first treatment one of the following regimens: melphalan (L-PAM) (41 patients), cyclophosphamide plus methotrexate plus 5-fluorouracil (CMF) (16 patients), cyclophospham